Gainey McKenna & Egleston Announces VimpelCom, Ltd. Class Action Litigation Update (Now Known As VEON Ltd.) (VEON)

NEW YORK, Sept. 25, 2017 (GLOBE NEWSWIRE) — Gainey McKenna & Egleston announces Class Action update regarding VEON, Ltd. (“VEON” or the Company”) (NASDAQ:VEON), previously known as VimpelCom, Ltd.

On December 9, 2016, Lead Plaintiff in the action filed an amended class action complaint.  The amended complaint asserts claims on behalf of all persons or entities that purchased VimpelCom securities (now VEON) between December 4, 2010 and November 3, 2015 inclusive (the “Class Period”), and seeks to pursue violations of the Securities Exchange Act of 1934 (the “Exchange Act”) and Rule 10(b)-5 promulgated thereunder.  Recently, the Court issued an important decision which denied the Company’s attempt to dismiss the class action.  In particular, the Court’s decision denied Defendants’ motion to dismiss and sustained most of the claims in the amended class action complaint.

A copy of the amended class action complaint and the Court’s decision can be found at our website at www.gme-law.com.

If you wish to discuss your rights or interests regarding this class action, please contact Thomas J. McKenna, Esq. or Gregory M. Egleston, Esq. of Gainey McKenna & Egleston at (212) 983-1300, or via e-mail at tjmckenna@gme-law.com or gegleston@gme-law.com.

Please visit our website at http://www.gme-law.com for more information about the firm.

Related Post
ATLANTA, May 11, 2018 (GLOBE NEWSWIRE) — CP Kelco, a leading global producer of specialty
Honoring Global Leaders Initiating Innovative, Transformative and Inspirational Breakthroughs DALLAS, May 10, 2018 (GLOBE NEWSWIRE)
เมืองซานดิเอโก, May 10, 2018 (GLOBE NEWSWIRE) — Invivoscribe Technologies Inc. ซึ่งเป็นบริษัทประกอบการวินิจฉัยอย่างแม่นยำระดับโลกในด้านเนื้องอกวิทยาและเวชศาสตร์และเวชศาสตร์ระดับโมเลกุลเฉพาะบุคคล ได้ประกาศการร่วมมือกับมหาวิทยาลัยอเมริกันศูนย์การแพทย์เบรุต (American University of